Celcuity (CELC) Capital Expenditures (2016 - 2025)
Celcuity (CELC) reported Capital Expenditures of $53,000 for Q4 2025, up 17.8% from $45,000 a year earlier but down 45.4% from the prior quarter.
Powered by 
Analysis
Celcuity (CELC) Capital Expenditures (2016 - 2025) Analysis & Trends
For FY2025, Celcuity posted Capital Expenditures of $249,000, down 0.4% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 22.7% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $250,000 in FY2024 (+156.0%), $97,644 in FY2023 (-38.5%), $158,768 in FY2022 (+93.9%) and $81,898 in FY2021 (-8.4%).
- Five-year quarterly Capital Expenditures spans a low of $4,854 in Q2 2023 and a high of $112,044 in Q4 2022.
- Year over year, Capital Expenditures gained in three of the last six quarters, with growth averaging 11.5%.
- The high point for year-over-year Capital Expenditures in five years was Q3 2023 (growth of 338.8%); the low point was Q2 2023 (a decline of 78.9%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $97,000 (Q3 2025), $39,000 (Q2 2025) and $60,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Celcuity | 3.90 Bn | 3.90 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Sep 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 90,000.00 |
| Dec 31, 2023 | 32,699.00 |
| Sep 30, 2023 | 53,104.00 |
| Jun 30, 2023 | 4,854.00 |
| Mar 31, 2023 | 6,987.00 |
| Dec 31, 2022 | 112,044.00 |
| Sep 30, 2022 | 12,103.00 |
| Jun 30, 2022 | 22,986.00 |
| Mar 31, 2022 | 11,635.00 |
| Dec 31, 2021 | 9,939.00 |
| Sep 30, 2021 | 14,062.00 |
| Jun 30, 2021 | 26,972.00 |
| Mar 31, 2021 | 30,925.00 |
API Access
Celcuity Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CELC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CELC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CELC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();